New research has revealed that gliomas in neurofibromatosis type 1 patients may respond well to immunotherapy due to their genetic vulnerabilities.
Browsing: Disease Area > Brain and neurologic
Fluorescent marker highlights glioma cells above normal brain tissue, allowing for safer, guided tumor removal.
An international team has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells.
A new therapeutic target, identified in glioblastoma, could be effective against a common immortality mechanism in one third of human cancers.
A new study, published in CNS Oncology estimates the survival benefit of adding tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
A valuable cache of brain cancer biomedical data, termed REMBRANDT, has been made freely accessible to researchers worldwide.
Checkpoint inhibitors increase median survival to 12.4 months, and more than double percentage of patients who survive 4 years or longer.
Interim blinded survival data has been released from the Phase III clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma patients; early findings from the 11-year study involving more than 300 people worldwide demonstrates promising survival results
In this article from CNS Oncology discover two case reports of adenocarcinoma and breast carcinoma that metastasized into an intracranial meningioma.
Researchers have reported that children with incurable brain tumors could benefit from a potentially life-extending treatment, if genetic testing is utilized to personalize their therapy. This personalized treatment has previously only been used in adults.